Clinical trial
Evaluation of Skin Health Improvement and Safety in AP Collagen Peptide: Randomized, Double-blind, Placebo-controlled
NCT05059197 is registered in ClinicalTrials.gov with Amorepacific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of Skin Health Improvement and Safety in AP Collagen Peptide: Randomized, Double-blind, Placebo-controlled
- Lead sponsor
- Amorepacific Corporation
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- December 15, 2020
- Completion date
- October 12, 2021
- Enrollment
- 54 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
dry skin